【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Respiratory Syncytial Virus (RSV) Infections 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of Respiratory Syncytial Virus (RSV) Infections 26
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Respiratory Syncytial Virus (RSV) Infections 33
Nov 11, 2014: Preclinical Data For GenVec’s RSV Vaccine Candidate Presented At The 9th RSV Symposium 33
Nov 10, 2014: ADMA Biologics To Present At The 9th International Respiratory Syncytial Virus Symposium 33
Nov 10, 2014: Novavax Initiates Phase 1 Clinical Trial of RSV F Vaccine in Pediatric Subjects 34
Nov 06, 2014: Ablynx To Present Pre-Clinical Proof-Of-Concept Results With Anti-Rsv Nanobody, ALX-0171, At 9th International Respiratory Syncytial Virus Symposium 34
Oct 26, 2014: Novavax Presents RSV F Protein Nanoparticle Vaccine Clinical Data at the 8th Vaccine & ISV Congress in Philadelphia 35
Oct 20, 2014: Mucosis Presents Data on Intranasal RSV Vaccine SynGEM at Vaccines 2014 Conference 35
Oct 14, 2014: Novavax Initiates Phase 2 Clinical Trial of RSV Vaccine in Elderly Subjects 36
Oct 13, 2014: Alios BioPharma Presented Positive Results of Its Anti-RSV Nucleoside Analog AL-8176 in a Phase 2 Challenge Study in Adults Infected With Respiratory Syncytial Virus (RSV) at IDWeek 36
Sep 16, 2014: Novavax Initiates Phase 2 Clinical Trial of RSV F-Protein Nanoparticle Vaccine Candidate in Healthy Third-Trimester Pregnant Women 37
Sep 08, 2014: Immunization of Pregnant Baboons With the RSV F Nanoparticle Vaccine Protects Infant Baboons Challenged With Respiratory Syncytial Virus in a Comparable Manner to Infants Prophylaxed With Palivizumab 38
Sep 06, 2014: Novavax Presents Data on RSV F Nanoparticle Vaccine Induced Monoclonal Antibody at ICAAC 38
Sep 04, 2014: Biota to Present Preclinical Data on RSV Compound BTA-C585 at ICAAC Meeting 39
Clinical Trial Profiles 40
Clinical Trial Overview of Top Companies 40
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
Novavax, Inc. 43
Clinical Trial Overview of Novavax, Inc. 43
GlaxoSmithKline plc 44
Clinical Trial Overview of GlaxoSmithKline plc 44
Gilead Sciences, Inc. 45
Clinical Trial Overview of Gilead Sciences, Inc. 45
AbbVie Inc. 46
Clinical Trial Overview of AbbVie Inc. 46
Abbott Laboratories 47
Clinical Trial Overview of Abbott Laboratories 47
Johnson & Johnson 48
Clinical Trial Overview of Johnson & Johnson 48
Alnylam Pharmaceuticals, Inc. 49
Clinical Trial Overview of Alnylam Pharmaceuticals, Inc. 49
Novartis AG 50
Clinical Trial Overview of Novartis AG 50
Ablynx NV 51
Clinical Trial Overview of Ablynx NV 51
Clinical Trial Overview of Top Institutes / Government 52
The National Institute of Allergy and Infectious Diseases 52
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 52
University of Texas M. D. Anderson Cancer Center 53
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 53
VU University Medical Center 54
Clinical Trial Overview of VU University Medical Center 54
Rambam Health Care Campus 55
Clinical Trial Overview of Rambam Health Care Campus 55
Fred Hutchinson Cancer Research Center 56
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 56
University Hospitals of Leicester NHS Trust 57
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 57
Imperial College London 58
Clinical Trial Overview of Imperial College London 58
Ziv Medical Center 59
Clinical Trial Overview of Ziv Medical Center 59
Sunnybrook Health Sciences Centre 60
Clinical Trial Overview of Sunnybrook Health Sciences Centre 60
Indiana University School of Medicine 61
Clinical Trial Overview of Indiana University School of Medicine 61
Five Key Clinical Profiles 62
Appendix 103
Abbreviations 103
Definitions 103
Research Methodology 104
Secondary Research 104
About GlobalData 105
Contact Us 105
Disclaimer 105
Source 105
【レポート販売概要】
■ タイトル：呼吸器合胞体ウイルス（RSV）感染症(Respiratory Syncytial Virus Infections)：世界の治験レビュー2014年下半期版■ 英文：Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H2, 2014
■ 発行日：2014年11月28日
■ 調査会社：GlobalData
■ 商品コード：GDHC2467CTIDB
■ 調査対象地域：グローバル
- 酸素療法の世界市場分析：製品別（酸素供給装置、シリンダー、コンセントレータ、液体酸素装置、PAP、酸素供給装置、マスク、鼻カニューレ、ベンチュリーマスク、非再呼吸式マスク、バッグバルブ、CPAP）、用途別（慢性閉塞性肺疾患、喘息、閉塞性睡眠時無呼吸、呼吸窮迫症候群、嚢胞性線維症、肺炎）、エンドユーザー別（在宅介護、病院）、セグメント予測The global oxygen therapy market is expected to reach USD 18.2 billion by 2024, according to a new study by Grand View Research, Inc. The increasing prevalence of major respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and obstructive sleep apnea, is a high impact rendering driver of oxygen therapy market. As per the estimates of the WHO, a consequential global ri …
- 重要インフラ保護ソリューションの世界市場：ネットワークセキュリティ、物理セキュリティ、レーダー、CBRNE、車両識別管理、セキュア通信Rise in the development of automation and ICT dependency, across the verticals, the need for ensuring cost effective solutions from cyber threats/attacks is driving the critical infrastructure protection market. Critical infrastructure security solutions ensure cost efficiency and reliability as they deploy both traditional physical security and the modern cyber security. Currently the focus of th …
- グローバル海上保安・国境保安市場（2014-2024）：競争環境、戦略的インサイトSynopsis This report shows the leading Maritime and Border Security market segments in various regions across the world. Details of top companies active across the global Maritime and Border Security market are provided, together with market size and forecast 2014-2024 for the main players across those areas. Summary The report provides a detailed analysis of the competitive landscape of the Marit …
- 世界の喘息及びCOPD（慢性閉塞性肺疾患）治療薬市場Asthma and COPD therapies – new study showing you trends, R&D progress, and predicted revenues Where’s the asthma and COPD therapies market heading? Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 335-page report provides 264 tables, charts, and graphs. Discover the most lucrative areas in the industry and the futur …
- イスラム式マイクロファイナンスの世界市場About Islamic Microfinance Islamic microfinance refers to the system of finance that is based on Islamic law, also known as “Sharia.” It combines the elements of “Islamic finance” and “microfinance.” The main feature of Islamic finance that differentiates it from conventional finance is the non-existence of a fixed, pre-determined interest in any financial transaction. Islamic microfinance has a m …
- VRゲームの世界市場2017-2021ABSTRACTAbout VR Gaming The virtual reality (VR) can be experienced using a head-mounted display (HMD) or glasses which display 3D experiences as part of their image. Some HMDs and glasses have options for additional sensory input in the form of audio or video. New forms of human-machine interactions are possible through the VR technology. Technavio’s analysts forecast the global VR gaming market …
- 世界の飼料用酵素市場：種類別（フィターゼ、カルボヒドラーゼ、およびプロテアーゼ）、家畜別（家禽、豚、反すう動物、水生動物）、由来別（微生物、植物、動物）、フォーム別（乾燥および液体）、地域別“Provision of cost-efficiency in the usage of feed and increasing demand for animal-based products, such as meat products, dairy products, and eggs, are projected to drive the growth of the global feed enzymes market.” The global feed enzymes market size is projected to grow from USD 1.2 billion in 2019 to USD 2.0 billion by 2025, at a CAGR of 9.1% during the forecast period. Provision of maintain …
- 創薬における人工知能（AI）の世界市場予測（～2024年）“Growing number of cross-industry collaborations and partnerships and the need to control drug discovery & development costs and reduce the overall time taken in this process are the key factors driving the AI in the drug discovery market.” The global AI in the drug discovery market is projected to reach USD 1,434 million by 2024 from USD 259 million in 2019, at a CAGR of 40.8% during the forecast …
- 世界の口腔衛生製品市場動向：ニュース・イベント（2014年5月）Synopsis The report provides a review of the latest news and key events in the global oral hygiene market during May 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global oral hygiene market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the glob …
- ラウリルエーテル硫酸ナトリウム（SLES）の世界市場2018-2022About Sodium Lauryl Ether Sulfate (SLES) SLES is an anionic surfactant that exhibits excellent wettability, solubility, foaming ability, and emulsifying property. It is extensively used in detergents and cleaners,personal care products, agrochemicals, antimicrobial, and medical chemicals. Technavio’s analysts forecast the global sodium lauryl ether sulfate (SLES) market to grow at a CAGR of 5.2% d …
- グローバル製油市場展望20142014 Refinery Outlook: High Refining Utilization in U.S Summary Report provides an overview of refining throughput activities forecast on a quarterly basis for 2014 by region compared to 2013 highlighting those areas where refining throughput volumes are forecast to be higher than or lower than last year’s levels. Report highlights the impact from new refining expansion projects to start-up during …
- 動物用成長促進剤および機能向上剤の世界市場：抗生物質、ホルモン、飼料用酵素、プロバイオティクス、プレバイオティクス、有機酸、植物、βアゴニストThe animal growth promoters market is expected to reach USD 9.60 Billion in 2020 from USD 7.56 Billion in 2015, growing at a CAGR of 5%. The global animal growth promoters market is segmented on the basis of product and animal. By product, the market is categorized into antibiotics, hormonal growth promoters, beta agonist growth promoters, feed enzymes, probiotics and prebiotics, organic acids, ph …
- 世界のバライト市場：市場規模、動向、メーカー動向Scope The report presents a thorough study of barite, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing barite production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: barite production …
- 塗料添加剤の世界市場：レオロジー調節剤、分散剤、湿潤剤、耐衝撃性改良剤、消泡剤The global market size of coating additives was USD 6.39 Billion in 2015 and is expected to reach USD 9.19 Billion by 2021, registering a CAGR of 6.1% during forecast period. The Asia-Pacific region dominated the coating additives market in terms of both volume and value. The increasing demand from the architecture, automobile, industrial, and wood & furniture industries in China, India, and Japan …
- 偏頭痛（Migraine）：グローバル医薬品市場予測及び分析（～2023）PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023 Summary The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of ma …
